Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban

ConclusionsIncreased copayments for brand‐name CFC‐free albuterol after the CFC ban did not lead to a decrease in children's albuterol use, but it led to a modest increase in OOP costs.

Source: Health Services Research - September 30, 2016 Category: Health Management Authors: Alison A. Galbraith, Vicki Fung, Lingling Li, Melissa G. Butler, James D. Nordin, John Hsu, David Smith, William M. Vollmer, Tracy A. Lieu, Stephen B. Soumerai, Ann Chen Wu Tags: Research Article Source Type: research